Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis

Journal of Medicinal Chemistry

Volumn 53, Issue 4, 2010, Pages 1579-1586

  Regino, Celeste Aida S ^a   Ogawa, Mikako ^a   Afford, Raphael ^a,b   Wong, Karen J ^a   Kosaka, Noboyuki ^a   Williams, Mark ^a,c   Feild, Brian J ^d   Takahashi, Masatoshi ^d   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAIC FREDERICK INC   (United States)

^d Shimazdu Scientific Instruments   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEXTRO GALACTOSE RECEPTOR; DIAGNOSTIC AGENT; GALACTOSE; GLUCOSE DERIVATIVE; HUMAN SERUM ALBUMIN; LECTIN RECEPTOR; RHODAMINE GREEN GALACTOSYLATED HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMATOUS PERITONITIS; CELL SURFACE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; ENDOSCOPY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGING SYSTEM; MOUSE; NONHUMAN; POLARIMETRY; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; GALACTOSAMINE; GLUCOSAMINE; GLUCOSE; GLYCOSYLATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PROTEIN BINDING; RECEPTORS, MITOGEN; RHODAMINES; SERUM ALBUMIN; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 77649217174     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm901228u     Document Type: Article

References (35)

1. Heron, M. P.; Hoyert, D. L.; Xu, J.; Scott, C; Tejada-Vera, B. Deaths: Preliminary data for 2006. Natl. Vital Stat. Rep. 2008, 56, 1-52.
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
3. Hoffman, R. M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat. Rev. Cancer 2005, 5, 796-806.
4. Hoffman, R. M.; Yang, M. Subcellular imaging in the live mouse. Nat. Protoc. 2006, 1, 775-782.
5. Hoffman, R. M.; Yang, M. Color-coded fluorescence imaging of tumor-host interactions. Nat. Protoc. 2006, 1, 9-928.
6. Hoffman, R. M.; Yang, M. Whole-body imaging with fluorescent proteins. Nat. Protoc. 2006, 1, 1429-1438.
7. Kishimoto, H.; Zhao, M.; Hayashi, K.; Urata, Y.; Tanaka, N.; Fujiwara, T.; Penman, S.; Hoffman, R. M. In vivo internal tumor illumintation by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 14515-14517.
8. Gunn, A. J.; Brechbiel, M. W.; Choyke, P. L. The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis. Expert Opin. Drug Delivery 2007, 4, 389-402.
9. Gunn, A. J.; Hama, Y.; Koyama, Y.; Kohn, E. C.; Choyke, P. L.; Kobayashi, H. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albuminconjugated fluorophore. Cancer Sci. DNLM 2007, 98, 1727-1733. (Pubitemid 47487908)
10. Stockert, R. J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 1995, 75, 591-609.
11. Hama, Y.; Urano, Y.; Koyama, Y.; Bernardo, M.; Choyke, P. L.; Kobayashi, H. A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. Bioconjugate Chem. 2006, 17, 1426-1431. (Pubitemid 44851486)
12. Hama, Y.; Urano, Y.; Koyama, Y.; Kamiya, M.; Bernardo, M.; Paik, R.; Krishna, M. C.; Choyke, P. L.; Kobayashi, H. In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Neoplasia 2006, 8, 607-612.
13. Hama, Y.; Urano, Y.; Koyama, Y.; Choyke, P. L.; Kobayashi, H. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem. Biophys. Res. Commun. 2006, 348, 807-813.
14. Hama, Y.; Urano, Y.; Koyama, Y.; Choyke, P. L.; Kobayashi, H. D-Galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green. J. Biomed. Opt. 2007, 12, 051501-1-051501-51509
15. Hama, Y.; Urano, Y.; Koyama, Y.; Choyke, P. L.; Kobayashi, H. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem. Biophys. Res. Commun. 2006, 348, 807-813.
16. Scott, D.; Nitecki, D. E.; Kindler, H.; Goodman, J. W. Immunogenicity of biotinylated hapten-avidin complexes. Mol. Immunol. 1984, 21, 1055-1060.
17. Stadalnik, R. C.; Vera, D. R.; Woodle, E. S.; Trudeau, W. L.; Porter, B. A.; Ward, R. E.; Krohn, K. A.; O'Grady, L. F. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J. Nucl. Med. 1985, 26, 1233-1242.
18. Ikuyo, E.; Kenjiro, O.; Atsushi, F.; Akira, N.; Shiro, M. Tc-99m GSA scintigraphy for evaluation of liver function. Correlations with histological grading and staging (new Inuyama classification). Jpn. J. Med. Imaging 2000, 19, 259-267.
19. Kim, E.-M.; Jeong, H.-J.; Park, I.-K.; Cho, C.-S.; Kim, C.-G.; Bom, H.-S. Hepatocyte-targeted nuclear imaging using 99mTcgalactosylated chitosan: conjugation, targeting, and biodistribution. J. Nucl. Med. 2005, 46, 141-145.
20. Suzuki, Y.; Kohno, Y.; Takeda, Y.; Hiraki, Y. Evaluation of liver function parameters by Tc-99m-GSA using multivariate analysis: a study of 47 clinical cases. Acta Med. Okayama 1999, 53, 225-232. (Pubitemid 129538473)
21. Mitsumori, A.; Nagaya, I.; Kimoto, S.; Akaki, S.; Togami, I.; Takeda, Y.; Joja, I.; Hiraki, Y. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galatosyl human serum albumin liver scintigraphy and computed tomography. Eur. J. Nucl. Med. 1998, 25, 1377-1382.
22. Schneider, P. D. Preoperative assessment of liver function. Surg. Clin. North Am. 2004, 84, 355-373.
23. Hama, Y.; Kosuda, S.; Iwasaki, Y.; Kaji, T.; Kusano, S. Technetium Tc 99m DTPA galactosyl human serum albumin to measure in hepatic functional reserve after transcatheter arterial embolization of the liver. Can. Assoc. Radiol. J. 2001, 52, 399-403.
24. Hama, Y.; Urano, Y.; Koyama, Y.; Gunn, A. J.; Choyke, P. L.; Kobayashi, H. A self-quenched galactosamine-serum albuminrhodamine X conjugate: a "smart" fluorescent molecular imaging probe synthesized with clincally applicable material for detecting peritoneal ovarian cancer metastases. Clin. Cancer Res. 2007, 13, 6335-6343.
25. Valuev, I. L.; Chupov, V. V.; Valuev, L. I. Chemical modification of polymers with physiologically active species using water-soluble carbodiimides. Biomaterials 1998, 19, 41-43.
26. Pieper, J. S.; Hafmans, T.; Veerkamp, J. H.; van Kuppevelt, T. H. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking and ultrastructural aspects. Biomaterials 2000, 21, 581-593.
27. Kitov, P. I.; Bundle, D. R. On the nature of multivalency effect: a thermodynamic model. J. Am. Chem. Soc. 2003, 125, 16271-16284.
28. Huang, T.-S.; DeLange, R. J. Egg white avidin. II. Isolation, composition, and amino acid sequences of the tryptic peptides. J. Biol. Chem. 1971, 246, 686-697.
29. Hama,Y.;Urano,Y.;Koyama,Y.;Kamiya,M.;Bernardo,M.; Paik, R. S.; Krishna, M. C.;Choyke, P. L.;Kobayashi,H. In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Neoplasia 2006, 8, 607-612.
30. Hama, Y.; Urano, Y.; Koyama, Y.; Choyke, P. L.; Kobayashi, H. Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. Cancer Res. 2007, 67, 3809-3817. (Pubitemid 46762168)
31. Stark, J. M.; Spitznagel, J. K. Immunogenecity of bovine serum albumin and its oligopolymers in CBAmice. J. Immunol. 1972, 108, 800-806.
32. Wainer, B. H.; Fitch, F. W.; Rothberg, R. M.; Fried, J. Morphine-3-succinyl-bovine serum albumin: an immunogenic hapten-protein conjugate. Science 1972, 176, 1143-1145.
33. Heddleson, R. A.; Allen, J. C. Relative immunogenecity of betallactoglobulin, bovine serum albumin, and model acid whey product. Nutr. Res. (N.Y.) 1997, 17, 505-514.
34. Imai, S.; Kiyozuka, Y.; Maeda, H.; Noda, T.; Hosick, H. L. Establishment and characterization of a human ovarian serous adenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen. Oncology 1990, 47, 177-184.
35. Kent, S.; Bluthe, R.-M.; Kelley, K. W.; Dantzer, R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13, 24-28.